NCT06516796View on ClinicalTrials.gov

Omitting of Lymphadenectomy is Acceptable for Lung Cancer Smaller Than 6 mm in Solid Size

CompletedOBSERVATIONAL
Enrollment

2,713

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

February 1, 2024

Conditions
Non-small Cell Lung Cancer
Interventions
OTHER

No intervention

Patients were retrospectively screened.

Trial Locations (1)

210029

Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

Liang Chen

OTHER